Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Physicians who Treat Rosacea (US)(?)

Council Members in this Study Group: 125

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Michael Bain, MD
Plastic and Reconstructive Physician
Michael A Bain, MD

Michael Bain, MD, MS, is a Plastic and Reconstructive Physician in private practice based in Southern California. He has experience in all areas of plastic and reconstructive surgery including bariatric, breast, cosmetic, and reconstructive surgery. Dr. Bain’s interests are in the ever changing nature...

Brian Lester, MD
Dermatologist
Brian W Lester, MD

Brian Lester, MD, is a Dermatologist in private practice in Massachusetts. His interests include clinical dermatology, cosmetic dermatology, dermatopathology, and dermatologic pharmaceuticals. He has experience with clinical trials involving a variety of agents used in psoriasis (e.g. retinoids and...

Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford UniversitySunil Dhawan, MD
Clinical Assistant Professor of Dermatology
Stanford University

Sunil Dhawan, MD, is a Clinical Assistant Professor of Dermatology at Stanford University. He has expertise in clinical dermatology including acne, rosacea, psoriasis, eczema, skin cancer, actinic keratosis, lasers and cosmetic dermatology, and managed care. Dr. Dhawan also runs the clinical trial division...

Michele Pauporte, MD, Dermatologist, Juva Skin and Laser CenterMichele Pauporte, MD
Dermatologist
Juva Skin and Laser Center

Michele Pauporte, MD, is a Dermatologist at Juva Skin and Laser Center, in New York City. Dr. Pauporte's areas of expertise include cosmetic procedures and the treatment of skin cancers (including Mohs micrographic surgery) and reconstructive surgery. She is also extremely experienced in the use of...

Jeffrey Weinberg
Director of Clinical Research - Dermatology
ST LUKE'S-ROOSEVELT HOSPITAL CENTER

Jeffrey Weinberg, MD, is the Director of the Clinical Research Center in the Department of Dermatology at St. Luke's-Roosevelt Hospital Center and Beth Israel Medical Center in New York. He is also an Assistant Clinical Professor in the Dermatology Department at Columbia University College of Physicians...

Kenneth Edelson
Owner
Kenneth Edelson, MD

Kenneth Edelson, MD, FAACS, is a Dermatologist in private practice in New York, since July 1980. He specializes in skin cancer as well as cosmetic dermatology, including lasers and IPL's for facial rejuvenation and skin tightening, vascular lesions, pigmentation, and cellulite. Dr. Edelson uses lasers...

Bruce Strober, MD, PhD, Director, Dermatology Clinical Trials, NYU Medical CenterBruce Strober, MD, PhD
Director, Dermatology Clinical Trials
NYU Medical Center

Bruce Strober, MD, PhD, is an Associate Director of the Dermatology Clinical Trials Unit, Co-Director of Psoriasis and Psoriatic Arthritis Center, and Assistant Professor at New York University. Dr. Strober is an expert on biologic therapies for psoriasis and his specialty includes general medical dermatology...

Alan Fleischer, MD
Professor and Chair of Dermatology
Wake Forest University School of Medicine - CC

Alan Fleischer, MD, is Professor and Chair of Dermatology at the Wake Forest University School of Medicine. In addition to his general and surgical dermatology practice, he has been primary investigator on dozens of Phase I through Phase IV clinical trials. Dr. Fleischer has published extensively on...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
A rough in the diamond | 08-27-2008
Author: GLG Expert Contributor

If truly an association, this will alter the use of this drug.

Will access to dermatology care suffer with increased cosmetic procedures ? | 08-01-2008
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University

 This article is important in that it describes a growing trend among dermatologists to offer a higher level of "customer service" for their cash paying cosmetic patients. This has contributed in a small way to the long waits for non cosmetic dermatology patients to be able to see a dermatologist....

Onglyza - ? engagement ring for Astra Zeneca and Bristol-Myers Squibb | 07-28-2008
Author: GLG Expert Contributor

DDP4 inhibitor class fairly new.  Another arrow in the theraputic quiver

Fractures from Fosamax??? | 07-18-2008
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: GLG Expert Contributor

Patients may ask about this.  Haven't heard anyone yet.

Will prescription drug spending decreases affect dermatology? | 07-18-2008
Analysis of: Patients Curb Prescription Spending | online.wsj.com
Author: Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University

This article is important in that it describes a worrying trend for branded  pharmaceutical companies. As copays for branded products go up and the patients economic status worsens, the use of these drugs will fall. This may be especially true for medications in dermatology, where the perceived...

View All GLG News by members of this Study Group

GLG InstituteSM Seminars with this Study Group's Leading Experts(?)

 

Recent Seminars

Most Common Company Types:

  • Office Based Private Practice or Clinic
  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Owner
  • Physician - Director
  • President
  • Partner
  • Physician - Department Chair
  • Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-10-07T13:45:18.680